Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
Public ClinicalTrials.gov record NCT04213326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic
Study identification
- NCT ID
- NCT04213326
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Exact Sciences Corporation
- Industry
- Enrollment
- 6,400 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2019
- Primary completion
- Jan 28, 2021
- Completion
- Jan 28, 2021
- Last update posted
- Jun 13, 2024
2019 – 2021
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sarah Cannon | Thousand Oaks | California | 23229 | — |
| Sarah Cannon | Denver | Colorado | 80220 | — |
| Sarah Cannon | Fort Walton Beach | Florida | 32547 | — |
| Sarah Cannon | Ocala | Florida | 34471 | — |
| Sarah Cannon | Pensacola | Florida | 32514 | — |
| Sarah Cannon | Augusta | Georgia | 30909 | — |
| Sarah Cannon | Macon | Georgia | 31217 | — |
| Sarah Cannon | Savannah | Georgia | 31404 | — |
| Sarah Cannon | Kansas City | Kansas | 64012 | — |
| Sarah Cannon | Overland Park | Kansas | 66209 | — |
| Sarah Cannon | Independence | Missouri | 64057 | — |
| Sarah Cannon | Las Vegas | Nevada | 89129 | — |
| Sarah Cannon | Nashville | Tennessee | 37203 | — |
| Sarah Cannon | Richmond | Virginia | 23229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04213326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04213326 live on ClinicalTrials.gov.